Good morning Ladies and Gents,
NICE, the National Institue of Health and Care excellence are asking for patients experiences of Cediranib in order to determine wether or not it should be avaliablefor women via the NHS.
We have been asked to nominate patients who would be willing to share their insight, and also asked Ovacome for a submission. Cediranib is not yet in general NHS use, but some of you may have had it as part of a clinical trial.
We would be most grateful if you would let us know if you have had Cediranib by emailing us at firstname.lastname@example.org.